Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-centre, open-label, phase 2, parallel-group, pilot, randomised, controlled trial. - Chan RJ; Crawford-Williams F; Han CY; Jones L; Chan A; McKavanagh D; Ryan M; Carrington C; Packer RL; Crichton M; Hart NH; McKinnell E; et al. (EClinicalMedicine, 2025)